Company intelligence / Profile preview

Sanaby Health Acquisition

Palo Alto, California, United States

Ownership: Private
Development stage: Other

Overview

Sanaby Health Acquisition was a healthcare-focused special purpose acquisition company formed to identify and merge with a business in digital health, life science tools and services, or innovative therapeutics. The company completed a Nasdaq IPO in October 2021 and traded under the symbols SANBU for units and SANB for Class A shares. It did not complete a business combination within its required timeframe and announced its liquidation effective October 19, 2022. As a SPAC, it did not operate a drug development pipeline or commercial healthcare products of its own.

Industry: Investors

Beyond the preview

Go deeper on Sanaby Health Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanaby Health Acquisition.

Explore the full profile